目的 利用心脏代谢指数（CMI）和轻量级梯度提升机（LightGBM）模型评估代谢综合征（MetS）患者靶器官损害风险，探究其性别特异性关联，为精准干预提供依据。方法 纳入2022年8月至2025年2月在惠州市第一人民医院住院的132例MetS患者以及健康体检者400例（即对照组，仅作为基线对比参数），以心肾损害、大血管病变为复合靶器官损害终点，选取CMI、年龄等为核心特征；构建LightGBM分类模型（70%训练集、30%测试集分层抽样），并采用100次随机拆分验证得出曲线下的面积（AUC）和95%置信区间（CI）并绘制校准曲线；以AUC评估性能，结合沙普利加性解释算法（SHAP）和偏依赖图（PDP）进行可解释性及性别分层分析。结果 基线对比显示，MetS患者CMI（6.8±2.3）高于对照组（3.2±1.1），靶器官损害（TOD）阳性率（57.6%）高于对照组（12.0%）（P均＜0.001）；LightGBM模型预测AUC达0.812，CMI为最重要预测特征（相对贡献度31.5%），且CMI与性别交互作用检验差异有统计学意义（P＜0.01）；CMI与靶器官损害呈非线性S形关联，风险拐点为5.7，高危平台期为7.5；女性风险加速阈值（CMI 5.0）早于男性（CMI 6.5）。结论 以健康人群为对照明确了MetS患者的高CMI水平与高TOD风险特征，LightGBM-SHAP框架明确了CMI的核心预测价值，性别特异性阈值为制定男女个性化早期干预策略提供量化指导，具有良好的临床应用潜力。

    Objective This study aims to use the cardiometabolic index（CMI）and the LightGBM model to assess the risk of target organ damage（TOD）in metabolic syndrome（MetS）patients，explore its gender-specific associations，and provide a basis for precise intervention．Methods MetS patients meeting diagnostic criteria and healthy individuals（the control group，used only as a baseline reference parameter）were enrolled．The composite endpoint of TOD was defined as cardiorenal damage and macro/microvascular lesions．Core features selected included CMI and age．A LightGBM classification model was constructed（70% training set，30% test set with stratified sampling），and 100 random splits were used for validation to generate the area under the curve（AUC） with 95% confidence interval（CI）and draw the calibration curve．Performance was assessed using AUC，combined with the SHAP algorithm and Partial Dependence Plot（PDP）for interpretability and gender-stratified analysis．Results Baseline comparison showed that the CMI level of MetS patients（6.8±2.3）was significantly higher than that of the control group（3.2±1.1），and the positive rate of TOD（57.6%）was significantly higher than that of the control group（12.0%）（both P＜0.001）．The LightGBM model achieved an AUC of 0.875 in prediction，with CMI as the most important predictive feature（relative contribution of 31.5%），and the interaction test between CMI and gender showed a significant difference（P＜0.01）．CMI showed a non-linear S-shaped association with TOD，with a risk inflection point at 5.7 and a high-risk plateau at 7.5．Significant gender differences were observed：the threshold for accelerated risk in females（CMI 5.0）was earlier than that in males（CMI 6.5）．Conclusions Using healthy individuals as controls clarifies the characteristics of high CMI levels and high TOD risk in MetS patients．The LightGBM-SHAP framework clarifies the core predictive value of CMI．The gender-specific thresholds provide quantitative guidance for formulating personalized early intervention strategies for males and females，demonstrating good potential for clinical application．

目的 了解疫情期间医护人员代谢综合征(MS)、高同型半胱氨酸血症(HHcy)的患病率、二者关系及靶器官损害。方法 选取2020年1月—2021年11月在天津市某三级综合医院的1 544名医护人员作为研究对象。测量人体指标,测定血液生化、免疫等指标。分析MS及其组分的患病率、HHcy的患病率及靶器官损害。采用χ²检验,比较MS组、HHcy组与对照组靶器官损害的差异。采用Logistic回归模型分析MS与HHcy的关系。结果 三级综合医院医护人员疫情期间MS患病率为23.7%,MS组分:中心性肥胖、高血压/高血压病、高甘油三酯、低高密度脂蛋白和高空腹葡萄糖/糖尿病的患病率分别为49.4%、19.3%、24.3%、0.5%和37%。HHcy的患病率为29.7%。MS组、HHcy组与对照组靶器官损害程度差异有统计学意义(P<0.001)。HHcy与MS无直接相关性。结论 疫情期间医护人员MS和HHcy患病率较高,与对照组相比有明显的靶器官损害,HHcy不是MS的独立危险因素。

Objective To explore the prevalence of metabolic syndrome (MS) and hyperhomocysteinemia (HHcy), their relationship and target organ damage among medical staff during the pandemic. Methods A total of 1 544 medical staff in a third-class general hospital in Tianjin from January 2020 to November 2021 were selected as the object of study. The indexes of human body were measured, and the indexes of blood biochemistry and immunity were detected. The prevalence of MS and its components, the prevalence of HHcy and target organ damage were analyzed. χ² test was used to analyze the difference of target organ damage among MS group, HHcy group and control group. The relationship between HHcy and MS was analyzed by Logistic regression model. Results The prevalence of MS among medical staff in the third-class general hospital during the pandemic was 23.7%. The prevalence of central obesity, hypertension / hypertension disease, high triglyceride, low high density lipoprotein cholesterol and high fasting plasma glucose/diabetes were 49.4%, 19.3%, 24.3%, 0.5% and 37%, respectively. The prevalence of HHcy was 29.7%. There was significant difference in target organ damage among MS group, HHcy group and control group (P<0.001). There was no direct correlation between HHcy and MS. Conclusions During the pandemic period, the prevalence of MS and HHcy in medical staff were high, and there was obvious target organ damage in those staff compared with the control staff. HHcy is not an independent risk factor of MS.

瘦素是维持人体能量代谢平衡的蛋白质,在人体中主要由白色脂肪组织分泌,通过与瘦素受体结合发挥作用。近年来有许多与瘦素相关的研究证明高血压患者及代谢综合征患者的血清瘦素水平较健康人群明显升高。两种疾病均可出现心室肥厚,蛋白尿,动脉粥样硬化等表现,说明二者存在共同的靶器官。瘦素代谢异常可出现瘦素抵抗并通过影响肾素-血管紧张素-醛固酮系统(renin angiotensin aldosterone system, RAAS)及炎症细胞因子来损伤靶器官。本文旨在总结瘦素在高血压及代谢综合征中的作用机制,并探讨瘦素对高血压合并代谢综合征靶器官损伤作用的研究进展。

Leptin is a protein that maintains the balance of energy metabolism in human body. It is mainly secreted by white adipose tissue in human body. In recent years, many studies have shown that the serum leptin level in patients with hypertension complicated with metabolic syndrome is significantly higher than that of healthy people. Both of the diseases can lead to left ventricular hypertrophy, proteinuria, atherosclerosis and other manifestations. The abnormal metabolism of leptin may contribute to leptin resistance which damages target organs by affecting the angiotensin aldosterone system and inflammatory cytokines. The aim of this article is to summarize the mechanism of leptin in hypertension and metabolic syndrome, and to explore its effect on the target organ damage in patients with hypertension complicated with metabolic syndrome.